Stem cell therapy for inflammatory bowel disease
نویسندگان
چکیده
منابع مشابه
Stem Cell Therapy in the Treatment of Inflammatory Bowel Disease
IBD: Inflammatory Bowel Disease ; UC: Ulcerative Colitis; CD: Crohn’s Diseases; TNF-α: Tumor Necrosis Factor α; IL12/23: Interleukin 12/23; IL-6R: Interleukin 6R; iRNA: information Ribonucleic acid; SC: Stem Cells; CT: Cell Therapy; MSC: Mesenchymal Stem Cells; HSC: Hematopoietic Stem Cells; 2,4,6-TNBA: 2,4,6-Trinitrobenzene Sulfonic Acid; SDF-1: Stromal Derived Factor-1; VEGF: Vasculoendotheli...
متن کاملInflammatory bowel disease: Moving toward a stem cell-based therapy.
The incidence and prevalence of Crohn's disease (CD) and ulcerative colitis (UC), the two major forms of inflammatory bowel diseases (IBD), are rising in western countries. The modern hygienic lifestyle is probably at the root of a disease where, in genetically susceptible hosts, the intestinal commensal flora triggers dysregulated immune and inflammatory responses. Current therapies ranging fr...
متن کاملP137: Stem Cell Therapy in Alzheimer’s Disease
Alzheimer disease (AD) is a progressive neurodegenerative brain disorder which plays an important role in neural cell destruction and as a result it causes memory loss in the patients. This disease is also the most common type of dementia which doesn’t completely respond to medical treatments so no certain cure is available. Recent studies show the advantages of using stem cells (SCs) in ...
متن کاملBiologic therapy for inflammatory bowel disease.
Despite all of the advances in our understanding of the pathophysiology of inflammatory bowel disease (IBD), we still do not know its cause. Some of the most recently available data are discussed in this review; however, this field is changing rapidly and it is increasingly becoming accepted that immunogenetics play an important role in the predisposition, modulation and perpetuation of IBD. Th...
متن کاملCombination therapy for inflammatory bowel disease
Biologic therapies such as infliximab and adalimumab have become mainstays of treatment for inflammatory bowel disease. Early studies suggested that combination therapy (CT) with infliximab and an immunomodulator drug such as azathioprine may help optimize biologic pharmacokinetics, minimize immunogenicity, and improve outcomes. The landmark SONIC trial in Crohn's disease and the UC SUCCESS tri...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Gastroenterology
سال: 2015
ISSN: 0944-1174,1435-5922
DOI: 10.1007/s00535-015-1040-9